secwatch / observer
8-K filed February 16, 2024, 6:59 PM ET ticker FRMM CIK 0001690080
other material confidence high sentiment neutral materiality 0.70

ATNF shareholders approve reverse stock split, expand equity plan, enable warrant exercise

FORUM MARKETS Inc

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

FORUM MARKETS Inc: Stockholders approved the Second Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan, increasing the maximum number of shares available for issuance from 470,000 to 4,249,933 shares (effective 2024-02-16).

Effective
2024-02-16
Exact text from the filing
The Second Amendment became effective at the time of stockholder approval.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

FORUM MARKETS Inc shareholders approved Approval of the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve Proposal Nos. 1 and 3 above at the 2024-02-16 meeting.

Outcome
passed
Meeting
2024-02-16
Exact text from the filing
Proposal No. 4: Approval of the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve Proposal Nos. 1 and 3 above
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

FORUM MARKETS Inc shareholders approved Approval of an amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of our common stock, par value $0.0001 per share, by a ratio of between one-for-four to one-for-forty, inclusive at the 2024-02-16 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2024-02-16
Exact text from the filing
Proposal No. 1: Approval of an amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of our common stock, par value $0.0001 per share, by a ratio of between one-for-four to one-for-forty, inclusive, with the exact ratio to be set at a whole number to be determined by our Board of Directors or a duly authorized committee thereof in its discretion, at any time after approval of the amendment and prior to February 16, 2025
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

FORUM MARKETS Inc shareholders approved Approval of the adoption of the Second Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan at the 2024-02-16 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2024-02-16
Exact text from the filing
Proposal No. 2: Approval of the adoption of the Second Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan
View on SEC.gov

84 governance changes filed in the last 30 days. Browse all governance changes →

FORUM MARKETS Inc filing history →

Source: SEC EDGAR
accession 0001213900-24-014908
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.